Education
About Us
Working with TipRanks
Follow Us
Carl Zeiss Meditec (DE:AFX)
XETRA:AFX
Total Valuation
Carl Zeiss Meditec has a market cap or net worth of €4.58B. The enterprise value is €4.64B.
Market Cap€4.58B
Enterprise Value€4.64B
Share Statistics
Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,440,570
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Carl Zeiss Meditec’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 4.63%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)4.63%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.00M
Profits Per Employee86.51K
Employee Count2,066
Asset Turnover0.61
Inventory Turnover1.82
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio28.9
PS Ratio0.00
PB Ratio2.17
Price to Fair Value3.10
Price to FCF42.58
Price to Operating Cash Flow27.05
PEG Ratio-1.51
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.07B and earned 178.73M in profits. Earnings per share was 2.01.
Revenue2.07B
Gross Profit1.09B
Operating Income176.35M
Pretax Income240.87M
Net Income178.73M
EBITDA403.06M
Earnings Per Share (EPS)2.01
Cash Flow
In the last 12 months, operating cash flow was 166.49M and capital expenditures -60.30M, giving a free cash flow of 106.19M billion.
Operating Cash Flow166.49M
Free Cash Flow106.19M
Free Cash Flow per Share1.19
Dividends & Yields
Carl Zeiss Meditec pays an annual dividend of €0.6, resulting in a dividend yield of 1.19%
Dividend Per Share€0.6
Dividend Yield1.19%
Payout Ratio29.20%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change-17.40%
50-Day Moving Average57.58
200-Day Moving Average56.90
Relative Strength Index (RSI)32.91
Average Volume (3m)149.85K
Important Dates
Carl Zeiss Meditec upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateMar 27, 2025
Financial Position
Carl Zeiss Meditec as a current ratio of 2.13, with Debt / Equity ratio of 7.08%
Current Ratio2.13
Quick Ratio1.19
Debt to Market Cap0.00
Net Debt to EBITDA0.33
Interest Coverage Ratio-12.10
Taxes
In the past 12 months, Carl Zeiss Meditec has paid 60.71M in taxes.
Income Tax60.71M
Effective Tax Rate0.25
Enterprise Valuation
Carl Zeiss Meditec EV to EBITDA ratio is 16.01, with an EV/FCF ratio of 67.84.
EV to Sales3.12
EV to EBITDA16.01
EV to Free Cash Flow67.84
EV to Operating Cash Flow26.09
Balance Sheet
Carl Zeiss Meditec has €51.45M in cash and marketable securities with €146.87M in debt, giving a net cash position of €95.42M billion.
Cash & Marketable Securities€51.45M
Total Debt€146.87M
Net Cash€95.42M
Net Cash Per Share€1.07
Tangible Book Value Per Share€4.13
Margins
Gross margin is 52.43%, with operating margin of 8.54%, and net profit margin of 8.65%.
Gross Margin52.43%
Operating Margin8.54%
Pretax Margin11.66%
Net Profit Margin8.65%
EBITDA Margin19.51%
EBIT Margin13.08%
Analyst Forecast
The average price target for Carl Zeiss Meditec is €62.55, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€62.55
Price Target Upside22.77% Upside
Analyst ConsensusHold
Analyst Count11
Revenue Growth Forecast5.21%
EPS Growth Forecast-39.36%